Galectin-10 as a Potential Biomarker for Eosinophilic Diseases

• Published in: Biomolecules (Basel, Switzerland) Vol. 12; no. 10; p. 1385
• Main Authors: Tomizawa, Hiroki, Yamada, Yoshiyuki, Arima, Misaki, Miyabe, Yui, Fukuchi, Mineyo, Hikichi, Haruka, Melo, Rossana C. N, Yamada, Takechiyo, Ueki, Shigeharu
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 27.09.2022; MDPI
• Subjects: Apoptosis; Asthma; Atopic dermatitis; Biomarkers; Carbohydrates; Care and treatment; Cell death; Charcot–Leyden crystals; Crystals; Cytoplasm; Degranulation; Diagnosis; eosinophil; Eosinophil disorders; eosinophil extracellular trap; Esophagitis; ETosis; Exocytosis; galectin-10; Granulomatosis; Health aspects; Inflammation; Lectins; Leukocytes (basophilic); Leukocytes (eosinophilic); Localization; Lymphocytes; Lymphocytes T; Myeloid leukemia; Physiological aspects; Plasma; Plasma membranes; Protein expression; Proteins; Review; Rhinitis; Sinusitis; Japan
• ISSN: 2218-273X; 2218-273X
• DOI: 10.3390/biom12101385

Galectin-10 is a member of the lectin family and one of the most abundant cytoplasmic proteins in human eosinophils. Except for some myeloid leukemia cells, basophils, and minor T cell populations, galectin-10 is exclusively present in eosinophils in the human body. Galectin-10 forms Charcot–Leyden crystals, which are observed in various eosinophilic diseases. Accumulating studies have indicated that galectin-10 acts as a new biomarker for disease activity, diagnosis, and treatment effectiveness in asthma, eosinophilic esophagitis, rhinitis, sinusitis, atopic dermatitis, and eosinophilic granulomatosis with polyangiitis. The extracellular release of galectin-10 is not mediated through conventional secretory processes (piecemeal degranulation or exocytosis), but rather by extracellular trap cell death (ETosis), which is an active cell death program. Eosinophils undergoing ETosis rapidly disintegrate their plasma membranes to release the majority of galectin-10. Therefore, elevated galectin-10 levels in serum and tissue suggest a high degree of eosinophil ETosis. To date, several studies have shown that galectin-10/Charcot–Leyden crystals are more than just markers for eosinophilic inflammation, but play functional roles in immunity. In this review, we focus on the close relationship between eosinophils and galectin-10, highlighting this protein as a potential new biomarker in eosinophilic diseases.